360 related articles for article (PubMed ID: 25687208)
21. Infliximab, Immunomodulators and Treatment Failures in Paediatric and Adolescent Patients with Crohn's Disease: a Nationwide Cohort Study.
Lund K; Larsen MD; Knudsen T; Kjeldsen J; Nielsen RG; Mertz Nørgård B
J Crohns Colitis; 2021 Apr; 15(4):575-582. PubMed ID: 32926166
[TBL] [Abstract][Full Text] [Related]
22. Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.
Calderón R; Estrada S; Ramírez de la Piscina P; Salvador M; Zabaleta S; Enciso C; Delgado E; García-Campos F
Rev Esp Enferm Dig; 2010 Feb; 102(2):145-6. PubMed ID: 20361852
[No Abstract] [Full Text] [Related]
23. Long-term efficacy of adalimumab in paediatric Crohn's disease patients naïve to other anti-TNF therapies.
Martín-de-Carpi J; Pociello N; Varea V
J Crohns Colitis; 2010 Nov; 4(5):594-8. PubMed ID: 21122566
[TBL] [Abstract][Full Text] [Related]
24. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
Schmidt C; Wittig BM; Moser C; Zeitz M; Stallmach A
Aliment Pharmacol Ther; 2006 Jul; 24(2):343-50. PubMed ID: 16842461
[TBL] [Abstract][Full Text] [Related]
25. [Biological therapy as treatment of inflammatory bowel diseases].
Agnholt J
Ugeskr Laeger; 2008 Jun; 170(24):2152-6. PubMed ID: 18565302
[TBL] [Abstract][Full Text] [Related]
26. Can vulvar edema be the presenting sign of Crohn's disease? A case series.
Rios Melendez S; Majluta A; Medina A; Restrepo R; Felipez LM
J Pediatr Gastroenterol Nutr; 2024 Feb; 78(2):289-294. PubMed ID: 38374559
[TBL] [Abstract][Full Text] [Related]
27. Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease.
Watanabe M; Hibi T; Mostafa NM; Chao J; Arora V; Camez A; Petersson J; Thakkar R
J Crohns Colitis; 2014 Nov; 8(11):1407-16. PubMed ID: 24874893
[TBL] [Abstract][Full Text] [Related]
28. Vulvar involvement in pediatric Crohn's disease: a systematic review.
Granese R; Calagna G; Morabito G; Carriero C; Perino A; Tonni G; Romano C
Arch Gynecol Obstet; 2018 Jan; 297(1):3-11. PubMed ID: 28948431
[TBL] [Abstract][Full Text] [Related]
29. Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients.
Baert F; Glorieus E; Reenaers C; D'Haens G; Peeters H; Franchimont D; Dewit O; Caenepeel P; Louis E; Van Assche G;
J Crohns Colitis; 2013 Mar; 7(2):154-60. PubMed ID: 22537637
[TBL] [Abstract][Full Text] [Related]
30. Metastatic Crohn's disease responding to metronidazole.
Duhra P; Paul CJ
Br J Dermatol; 1988 Jul; 119(1):87-91. PubMed ID: 3408668
[TBL] [Abstract][Full Text] [Related]
31. Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: a large single centre experience.
Sprakes MB; Ford AC; Warren L; Greer D; Hamlin J
J Crohns Colitis; 2012 Mar; 6(2):143-53. PubMed ID: 22325168
[TBL] [Abstract][Full Text] [Related]
32. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.
Molander P; Sipponen T; Kemppainen H; Jussila A; Blomster T; Koskela R; Nissinen M; Rautiainen H; Kuisma J; Kolho KL; Färkkilä M
J Crohns Colitis; 2013 Oct; 7(9):730-5. PubMed ID: 23182163
[TBL] [Abstract][Full Text] [Related]
33. Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: predictors of efficacy in clinical practice.
Echarri A; Ollero V; Barreiro-de Acosta M; Fernández-Villaverde A; Hernández V; Lorenzo A; Pereira S; Carpio D; Castro J;
Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):430-5. PubMed ID: 25874517
[TBL] [Abstract][Full Text] [Related]
34. Vulval Crohn's disease-- a multi-specialty approach.
Bhaduri S; Jenkinson S; Lewis F
Int J STD AIDS; 2005 Jul; 16(7):512-4. PubMed ID: 16004636
[TBL] [Abstract][Full Text] [Related]
35. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G
J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
[TBL] [Abstract][Full Text] [Related]
36. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
D'Haens GR; Panaccione R; Higgins PD; Vermeire S; Gassull M; Chowers Y; Hanauer SB; Herfarth H; Hommes DW; Kamm M; Löfberg R; Quary A; Sands B; Sood A; Watermeyer G; Lashner B; Lémann M; Plevy S; Reinisch W; Schreiber S; Siegel C; Targan S; Watanabe M; Feagan B; Sandborn WJ; Colombel JF; Travis S
Am J Gastroenterol; 2011 Feb; 106(2):199-212; quiz 213. PubMed ID: 21045814
[TBL] [Abstract][Full Text] [Related]
37. Genital fistulas in female Crohn's disease patients.: clinical characteristics and response to therapy.
de la Poza G; López-Sanroman A; Taxonera C; Marín-Jimenez I; Gisbert JP; Bermejo F; Opio V; Muriel A
J Crohns Colitis; 2012 Apr; 6(3):276-80. PubMed ID: 22405162
[TBL] [Abstract][Full Text] [Related]
38. Addition of an immunomodulator as a rescue therapy for loss of response to adalimumab dose escalation in patients with Crohn's disease.
Papamichael K; Karatzas P; Mantzaris GJ
J Crohns Colitis; 2015 Jul; 9(7):589-90. PubMed ID: 25863276
[No Abstract] [Full Text] [Related]
39. Concerns and Side Effects of Azathioprine During Adalimumab Induction and Maintenance Therapy for Japanese Patients With Crohn's Disease: A Subanalysis of a Prospective Randomised Clinical Trial [DIAMOND Study].
Hisamatsu T; Matsumoto T; Watanabe K; Nakase H; Motoya S; Yoshimura N; Ishida T; Kato S; Nakagawa T; Esaki M; Nagahori M; Matsui T; Naito Y; Kanai T; Suzuki Y; Nojima M; Watanabe M; Hibi T;
J Crohns Colitis; 2019 Sep; 13(9):1097-1104. PubMed ID: 30753377
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment with adalimumab in infliximab-resistant Crohn's disease.
Barthel HR; Gille T; Halbsguth A; Kramer M
J Gastroenterol Hepatol; 2005 Sep; 20(9):1464-5. PubMed ID: 16105142
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
